BioreclamationIVT, provider of biospecimens and related services, appointed Karen Sasse to the newly created position of Vice President of global quality and compliance.
Sasse will be responsible for the company’s quality assurance and quality control activities worldwide.
Jeff Gatz, CEO BioreclamationIVT, said: “We are delighted to have an operations professional of Karen’s calibre join our growing team. Her drive, strong project management skills and superlative attention to detail will help to ensure that our biological products continue to exceed our customers’ highest expectations.
Sasse said: "I am excited to become part of the BioreclamationIVT team at this inflection point in its growth. I look forward to partnering with our customers and helping to facilitate drug discovery and development on a global basis.”
BioreclamationIVT provides biopharmaceutical companies with specialised in vitro products and services to identify the mechanisms and markers of disease and to better understand drug metabolism and toxicity responses leading to expedited diagnostic and new drug development.
Sasse has more than 25 years of experience in product manufacturing, development, quality control and technical support.
She previously worked at the Precision Valve Corporation, alongside aerosol valve inventor Robert Abplanalp and helped to establish the company’s ISO Quality Management System for its US sites.
Her role at Precision prepared her for subsequent positions in quality management and regulatory affairs in the medical device, cosmetics, over-the-counter drug and luxury goods industries.
Sasse has a proven record of process improvement, demonstrated through corporate and government agency metrics, and third-party assessments.
